Abstract

Bovine mastitis is an inflammation of mammary gland parenchyma in cows. It is caused by multiple pathogens that result in economic losses because of the reduction in milk production and poor quality of the milk. It is commonly caused by bacteria that multiply in the mammary gland and regional lymph nodes, damaging the mammary parenchyma. The present study focuses on the bovine mastitis treating capacity of zinc oxide nanoparticles by examining in vitro antibacterial activity, MIC and MBC against pathogens isolated and identified from sub-clinical mastitis in dairy cows. Zinc oxide nanoparticles were synthesized both chemically and green methods from a plant extract of Coriandrum sativum and characterized for phase and microstructural analysis. The milk sample from subclinical mastitis cows was collected from the veterinary hospital. The bacteriological examination revealed the presence of S. aureus and E. coli . The antibacterial activity of the zinc oxide nanoparticle was evaluated at 650, 850, 1300, 1700, 1950 and 2500 µg/ml concentrations and the minimum inhibitory concentration was found to be 650 µg/ml and 850 µg/ml for S.aureus and E.coli respectively, and minimum bactericidal concentration was 650 µg/ml and 1700 µg/ml for S. aureus and E. coli respectively. Keywords: Antibacterial activity, bovine subclinical Mastitis, Coriandrum sativum, chemical synthesis, green synthesis, minimum inhibitory concentration, minimum bactericidal concentration, zinc oxide nanoparticles DOI : 10.7176/CMR/11-10-01 Publication date: December 31 st 2019

Highlights

  • The world human population is expected to reach 9.4 billion by 2050 (Lutz et al 2017)

  • The bacteria isolated in this investigation are, the more frequently isolated bacterial causes of subclinical mastitis in bovine, this was in www.iiste.org agreement with the findings from other researches (Günther et al, 2011; Joshi & Gokhale, 2006; Seyoum, Kefyalew, Abera, & Abdela, 2018)

  • The antibiotic activity of the nanoparticle against common causes of subclinical bovine mastitis was investigated as an alternative treatment approach for mastitis in the dairy cow

Read more

Summary

Introduction

The world human population is expected to reach 9.4 billion by 2050 (Lutz et al 2017). Bovine mastitis is mammary gland parenchyma inflammation and it is one of the important diseases in the dairy industry. It is the most complex dairy cow disease which is negatively affecting milk production. Drugs used for control, prevention and treatment of mastitis are not effective currently, this is mainly due to the development of resistance to wide range antibiotics used, as these drugs have been used for a long period of time and other possible causes (El-Jakee et al 2013; Memon et al 2013; Raguvaran et al 2015), (Bradley et al 2007; Stevens et al 2019)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call